IPO registrations (S-1, F-1) · Registrants
Beyond Air, Inc.
- SEC CIK
- 1641631 · filings on EDGAR ↗
- Former names
- AIT Therapeutics, Inc. (2017–2019); KokiCare, Inc. (2015–2016)
- Registration
- Form S-1, first filed 2015-10-01, last 2025-12-11; 7 initial registrations, 8 amendments
- Outcome
- Declared effective 2016-01-22
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 900 STEWART AVENUE, SUITE 301, Garden City, NY 11530
- EIN
- 47-3812456
- Ticker
- XAIR (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Beyond Air, Inc. on the corporate pages
Offering terms
- Shares offered
- 1,600,000
- Listing
- Nasdaq under the symbol XAIR
- Lead underwriters
- of Contents
- Syndicate
- Market and Industry Data
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: BEYOND AIR, INC Fuzzy (name and state)
- Business registration: BEYOND AIR, INC. Fuzzy (name and state)
- Form D issuer: Beyond Air, Inc. EXACT (CIK (EXACT))
- SEC filer: AIT Therapeutics, Inc. EXACT (CIK (EXACT))
Filings 35
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-10-01 | S-1 | S-1 (registration) | KokiCare, Inc. | 0001078782-15-001562 ↗ |
| 2015-12-11 | S-1/A | S-1/A (amendment) | KokiCare, Inc. | 0001078782-15-001999 ↗ |
| 2016-01-05 | S-1/A | S-1/A (amendment) | KokiCare, Inc. | 0001078782-16-002127 ↗ |
| 2016-01-22 | EFFECT | EFFECT (declared effective) | KokiCare, Inc. | 9999999995-16-003583 ↗ |
| 2017-02-27 | S-1 | S-1 (registration) | AIT Therapeutics, Inc. | 0001178913-17-000658 ↗ |
| 2017-05-02 | S-1/A | S-1/A (amendment) | AIT Therapeutics, Inc. | 0001178913-17-001259 ↗ |
| 2017-05-19 | S-1/A | S-1/A (amendment) | AIT Therapeutics, Inc. | 0001178913-17-001551 ↗ |
| 2017-05-23 | S-1/A | S-1/A (amendment) | AIT Therapeutics, Inc. | 0001178913-17-001577 ↗ |
| 2017-05-26 | EFFECT | EFFECT (declared effective) | AIT Therapeutics, Inc. | 9999999995-17-001392 ↗ |
| 2017-06-09 | S-1 | S-1 (registration) | AIT Therapeutics, Inc. | 0001178913-17-001786 ↗ |
| 2017-06-16 | EFFECT | EFFECT (declared effective) | AIT Therapeutics, Inc. | 9999999995-17-001588 ↗ |
| 2018-03-28 | S-1 | S-1 (registration) | AIT Therapeutics, Inc. | 0001178913-18-001003 ↗ |
| 2018-03-29 | S-1/A | S-1/A (amendment) | AIT Therapeutics, Inc. | 0001178913-18-001008 ↗ |
| 2018-05-07 | S-1/A | S-1/A (amendment) | AIT Therapeutics, Inc. | 0001178913-18-001491 ↗ |
| 2018-05-09 | EFFECT | EFFECT (declared effective) | AIT Therapeutics, Inc. | 9999999995-18-001186 ↗ |
| 2018-10-03 | S-1 | S-1 (registration) | AIT Therapeutics, Inc. | 0001493152-18-014033 ↗ |
| 2018-10-03 | EFFECT | EFFECT (declared effective) | AIT Therapeutics, Inc. | 9999999995-18-002527 ↗ |
| 2018-10-12 | EFFECT | EFFECT (declared effective) | AIT Therapeutics, Inc. | 9999999995-18-002615 ↗ |
| 2019-07-02 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-19-001517 ↗ |
| 2019-07-24 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-19-001669 ↗ |
| 2019-09-11 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-19-002064 ↗ |
| 2020-01-14 | S-1 | S-1 (registration) | Beyond Air, Inc. | 0001493152-20-000586 ↗ |
| 2020-01-23 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-20-000148 ↗ |
| 2020-05-11 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-20-001119 ↗ |
| 2022-02-01 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-22-000298 ↗ |
| 2023-08-21 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-23-002459 ↗ |
| 2024-08-30 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-24-002701 ↗ |
| 2024-11-26 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-24-003586 ↗ |
| 2025-02-10 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-25-000378 ↗ |
| 2025-09-30 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-25-003253 ↗ |
| 2025-11-21 | S-1 | S-1 (registration) | Beyond Air, Inc. | 0001493152-25-024614 ↗ |
| 2025-12-11 | S-1/A | S-1/A (amendment) | Beyond Air, Inc. | 0001493152-25-027294 ↗ |
| 2025-12-15 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-25-003736 ↗ |
| 2026-02-09 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-26-000487 ↗ |
| 2026-08-24 | EFFECT | EFFECT (declared effective) | Beyond Air, Inc. | 9999999995-26-002748 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | S-1/A | registration statement | $1.95 | 1,600,000 | $3,120,000 | Nasdaq XAIR | 2 | primary document; price line, shares headline, proceeds computed, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Av-Gay Yossef | Director | 1 | 2017 | ||
| Aviv Haim | Officer | Chief Financial Officer | 2 | 2017 | |
| Avniel Amir | Director,Officer | Chief Business Officer; COO and President; President & CEO; President & COO; President, COO | 35 | 2017–2024 | |
| Raved Ari | Director | 3 | 2017–2018 | ||
| ZELDIS JEROME B | Director | 1 | 2017 | ||
| Grossman David | Director; Director,Officer | Secretary | 2 | 2017–2018 | |
| Lisi Steven A. | Director; Director,Officer | CEO and Chairman; CEO and Chairman of the Board; CEO, Chairman | 38 | 2017–2025 | |
| BENTSUR RON | Director | 27 | 2017–2024 | ||
| Lee Yoori | Director | 14 | 2018–2025 | ||
| Lucera Erick | Director | 13 | 2018–2025 | ||
| BECK DOUGLAS | Officer | CFO; Chief Financial Officer | 10 | 2018–2021 | |
| Carey Robert | Director | 40 | 2019–2025 | ||
| Forbes William P | Director | 11 | 2019–2025 | ||
| Larson Douglas Quinton | Officer | Chief Financial Officer | 10 | 2021–2025 | |
| Gaul Michael A. | Officer | Chief Operating Officer | 12 | 2022–2025 | |
| Myers Jeff Lynn | Officer | Chief Medical Officer | 3 | 2023 | |
| Goodman Robert Scott | Director; Director,Officer | Chief Executive Officer | 4 | 2025–2026 | |
| MOORHEAD DANIEL J | Officer | Chief Financial Officer | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-10-11 | Beyond Air, Inc. | Biotechnology | $20,600,000 | $20,600,000 | 15 | 1 |
| 2024-07-09 | Beyond Air, Inc. | Biotechnology | $128,000 | $128,000 | 2 | 1 |
| 2023-06-28 | Beyond Air, Inc. | Biotechnology | $1,375,000 | $1,375,000 | 2 | 1 |
| 2019-06-18 | AIT Therapeutics, Inc. | Biotechnology | $7,960,635 | $7,960,635 | 47 | 1 |
| 2018-03-01 | AIT Therapeutics, Inc. | Pharmaceuticals | $9,810,155 | $9,810,155 | 58 | 1 |
| 2017-04-12 | AIT Therapeutics, Inc. | Pharmaceuticals | $10,000,000 | $663,000 | 22 | 1 |
| 2017-01-31 | AIT Therapeutics, Inc. | Pharmaceuticals | $36,978,258 | $36,978,258 | 58 | 1 |
| 2015-05-08 | KokiCare, Inc. | Other Technology | $10,000 | $0 | 0 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | BEYOND AIR, INC | NY | State business registries | name and state |
| Business registration | BEYOND AIR, INC. | NY | State business registries | name and state |
| Form D issuer | Beyond Air, Inc. | NY | Form D private offerings | CIK (EXACT) |
| Paying company | Beyond Air, Inc. | NY | Open Payments (drug and device company payments) | name and state |
| Patent assignee | BEYOND AIR LTD | NY | Patents (USPTO) | name and state |
| SEC filer | Beyond Air, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Beyond Air, Inc. | NY | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NY first:
- SWISSRAY INTERNATIONAL INC NY
- BIOPHAN TECHNOLOGIES INC NY
- ANGIODYNAMICS INC NY
- DarioHealth Corp. NY
- iNeedMD Holdings, Inc. NY
- Nemaura Medical Inc. NY
- PAVmed Inc. NY
- OMNIA WELLNESS INC. NY
- INTELLIGENT BIO SOLUTIONS INC. NY
- Lucid Diagnostics Inc. NY
In other datasets, the same topic (Technology) in NY:
- Lobbying client: 1ST ROCHDALE COOPERATIVE GROUP LTD (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology